News headlines about Hospital Co. of America (NYSE:HCA) have been trending somewhat positive on Monday, Accern reports. Accern scores the sentiment of media coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Hospital Co. of America earned a coverage optimism score of 0.10 on Accern’s scale. Accern also gave headlines about the company an impact score of 46.0562986291437 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
Here are some of the headlines that may have impacted Accern’s analysis:
- ICU Nurse Educator at The Medical Center of Aurora Receives HCA Excellence in Nursing Award (pr.com)
- HCA Healthcare, Inc. — Moody’s upgrades HCA Healthcare’s CFR to Ba1; outlook stable (finance.yahoo.com)
- Hospital Co. of America (HCA) Upgraded to “Buy” by Zacks Investment Research (americanbankingnews.com)
- Hospital Co. of America (HCA) Upgraded at ValuEngine (americanbankingnews.com)
- Hospital Co. of America’s (HCA) “Buy” Rating Reaffirmed at Piper Jaffray (americanbankingnews.com)
Shares of Hospital Co. of America stock traded up $0.07 during trading hours on Monday, hitting $96.31. The company had a trading volume of 1,249,934 shares, compared to its average volume of 2,192,772. Hospital Co. of America has a twelve month low of $71.18 and a twelve month high of $106.84. The company has a current ratio of 1.62, a quick ratio of 1.36 and a debt-to-equity ratio of -6.58. The stock has a market cap of $33,674.73, a price-to-earnings ratio of 14.61, a PEG ratio of 0.96 and a beta of 0.47.
The business also recently announced a quarterly dividend, which was paid on Friday, March 30th. Stockholders of record on Thursday, March 1st were issued a $0.35 dividend. This represents a $1.40 annualized dividend and a dividend yield of 1.45%. The ex-dividend date was Wednesday, February 28th. Hospital Co. of America’s payout ratio is 21.24%.
Several equities research analysts recently weighed in on HCA shares. Citigroup raised shares of Hospital Co. of America from a “neutral” rating to a “buy” rating in a research note on Tuesday, December 12th. Zacks Investment Research raised shares of Hospital Co. of America from a “strong sell” rating to a “hold” rating in a research note on Tuesday, December 19th. Morgan Stanley downgraded shares of Hospital Co. of America from an “equal weight” rating to an “underweight” rating and set a $85.00 target price on the stock. in a research note on Wednesday, December 20th. SunTrust Banks set a $105.00 price objective on shares of Hospital Co. of America and gave the company a “buy” rating in a research report on Thursday, December 21st. Finally, Credit Suisse Group reissued an “outperform” rating and issued a $25.00 price objective on shares of Hospital Co. of America in a research report on Tuesday, December 26th. Three equities research analysts have rated the stock with a sell rating, six have given a hold rating and seventeen have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $105.95.
In related news, SVP Joseph A. Sowell III sold 58,175 shares of the stock in a transaction on Friday, January 26th. The shares were sold at an average price of $95.00, for a total transaction of $5,526,625.00. Following the completion of the sale, the senior vice president now owns 40,536 shares in the company, valued at approximately $3,850,920. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Bill B. Rutherford sold 48,462 shares of the stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $102.42, for a total transaction of $4,963,478.04. Following the sale, the chief financial officer now owns 41,269 shares of the company’s stock, valued at approximately $4,226,770.98. The disclosure for this sale can be found here. In the last 90 days, insiders sold 479,918 shares of company stock valued at $48,186,093. Company insiders own 2.80% of the company’s stock.
TRADEMARK VIOLATION WARNING: “Somewhat Positive News Coverage Somewhat Unlikely to Impact Hospital Co. of America (HCA) Share Price” was first reported by Ticker Report and is the property of of Ticker Report. If you are accessing this piece on another website, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The original version of this piece can be accessed at https://www.tickerreport.com/banking-finance/3344281/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-hospital-co-of-america-hca-share-price.html.
About Hospital Co. of America
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Receive News & Ratings for Hospital Co. of America Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hospital Co. of America and related companies with MarketBeat.com's FREE daily email newsletter.